NeuroClimax Gold™ (Max) – 3-Ingredient Nasal Spray | 1-Month Supply

NeuroClimax Gold™ (Max) — Three-Ingredient Intranasal Formulation

Three active ingredients. Distinct scientific backgrounds. One proprietary formulation.

NeuroClimax Gold™ (Max) is a proprietary intranasal nootropic formulation developed by CNS Curative Technologies LLC.

Unlike the single-active-ingredient NeuroClimax Gold (Simple), Gold (Max) combines three compounds: kinetin, Noopept, and centrophenoxine.

These compounds have been investigated in scientific research involving mitochondrial biology, neuronal signaling, synaptic plasticity, and cognitive processes.

The formulation reflects CNS Curative's interest in multiple biological pathways associated with neuronal function.

Important: Research findings involving individual ingredients do not establish the clinical effectiveness or safety of the finished NeuroClimax Gold (Max) formulation.

What Makes NeuroClimax Gold™ (Max) Different?

The distinguishing feature of NeuroClimax Gold (Max) is its three-active-ingredient composition.

• Three active ingredients: Kinetin, Noopept, and centrophenoxine.
• Research background: Compounds investigated in relation to mitochondrial function, neuronal signaling, and cognitive processes.
• Delivery format: Proprietary intranasal spray formulation.
• Product quantity: One-month supply, as described by CNS Curative.
• Formulation distinction: A broader active-ingredient composition than NeuroClimax Gold (Simple).
• Manufacturer: CNS Curative Technologies LLC.

Gold (Max) offers a different formulation composition, not a demonstrated clinical advantage over the other NeuroClimax products.

Understanding the Three Active Ingredients

1. Kinetin — PINK1 and Mitochondrial Research

Kinetin has been investigated in research involving PTEN-induced kinase 1 (PINK1), a mitochondrial-associated protein involved in mitochondrial quality control and cellular stress responses.

Published preclinical investigations have explored how kinetin-related compounds interact with PINK1-dependent signaling.

These pathways are relevant to scientific investigations of mitochondrial biology and neuronal function.

Research involving PINK1 provides part of the scientific rationale for including kinetin in the NeuroClimax Gold formulation.

Research context: Hertz et al., 2013; Soman et al., 2021.

2. Noopept — Neuronal and Neurotrophic Signaling Research

Noopept is a synthetic nootropic compound investigated in experimental studies involving learning, memory-related processes, and neuronal signaling.

Preclinical studies have examined its relationship with:

• Neurotrophic signaling pathways.
• Synaptic plasticity.
• Glutamatergic neurotransmission.
• Learning and memory-related biological processes.

Some investigations have examined pathways involving neurotrophic factors, including brain-derived neurotrophic factor (BDNF).

These findings provide scientific background for Noopept but do not establish that NeuroClimax Gold (Max) improves memory or cognition in humans.

Research context: Ostrovskaya et al., 2008.

3. Centrophenoxine — Cholinergic and Cognitive Research

Centrophenoxine is a compound investigated in research involving cholinergic function, cellular metabolism, and cognitive processes.

Cholinergic signaling is associated with several important neurological functions, including attention, learning, and memory.

Experimental and clinical investigations have examined centrophenoxine in relation to cognitive function, including studies involving aging populations.

These investigations contribute to the scientific rationale for including centrophenoxine alongside kinetin and Noopept.

However, evidence concerning centrophenoxine alone cannot be assumed to demonstrate the effects of the combined NeuroClimax Gold (Max) formulation.

Research context: Marcer & Hopkins, 1977.

The Scientific Foundation Behind NeuroClimax Gold™

Mitochondrial Function and Neuronal Biology

Mitochondria are involved in cellular energy production and other essential biological processes.

Scientific research has examined relationships between mitochondrial function, oxidative stress, neuronal maintenance, and age-related changes in cellular biology.

These biological processes form part of the broader research background informing CNS Curative's formulation development.

BDNF and Synaptic Plasticity

Brain-derived neurotrophic factor (BDNF) is a protein involved in neuronal survival, development, and synaptic plasticity.

Scientific investigations have examined how neurotrophic signaling relates to learning, memory, and neuronal responses to cellular stress.

Research has also explored interactions between mitochondrial processes, oxidative stress, and neurotrophic signaling.

These investigations provide biological context for the NeuroClimax development approach.

Research references: Costa et al., 2015; Dagda & Das Banerjee, 2015.

The relationships described above are areas of scientific investigation, not demonstrated therapeutic effects of the finished product.

NeuroClimax Gold™ (Max) vs. Gold™ (Simple)

Both formulations belong to the NeuroClimax Gold product family, but their active-ingredient compositions are different.

NeuroClimax Gold™ (Max)

Three active ingredients:

• Kinetin: Investigated in research involving PINK1-related mitochondrial signaling.
• Noopept: Studied in experimental research involving neuronal signaling and memory-related processes.
• Centrophenoxine: Investigated in relation to cholinergic function and cognitive processes.

Gold (Max) combines three compounds with distinct scientific research backgrounds.

NeuroClimax Gold™ (Simple)

One active ingredient:

• Kinetin: Investigated in research involving PINK1-related mitochondrial biology.

Gold (Simple) offers a streamlined, single-active-ingredient formulation.

Which Formulation Should You Explore?

If you want to examine a formulation containing kinetin alone, review NeuroClimax Gold (Simple).

If you are interested in understanding a formulation combining kinetin, Noopept, and centrophenoxine, explore NeuroClimax Gold (Max).

The choice should be based on verified ingredient information, product labeling, relevant safety considerations, and professional advice where appropriate.

Note: The two formulations have different compositions. This comparison does not establish differences in clinical effectiveness or safety.

Explore NeuroClimax Gold™ (Simple)

Understanding the Intranasal Delivery System

NeuroClimax Gold (Max) uses an intranasal administration format rather than conventional oral delivery.

Intranasal delivery is an area of pharmaceutical research because the nasal cavity provides an alternative route for administering certain compounds.

The absorption, distribution, safety, and effectiveness of any intranasal product depend on the specific formulation and supporting evidence.

The intranasal delivery format alone does not establish superior brain delivery, increased bioavailability, or clinical effectiveness.

Additional Formulation Components

According to CNS Curative's existing product information, the formulation incorporates additional excipients intended for functions such as solubilization, preservation, and formulation stability.

The company describes components including:

• Cyclodextrins.
• Preservative agents.
• Emulsifying or solubilizing agents.
• Soothing agents and other formulation excipients.

This information describes ingredient categories from the company's original documentation, not a verified complete ingredient declaration.

Customers should consult the current product label or contact CNS Curative Technologies for the exact inactive ingredients and concentrations.

Manufacturing and Quality Information

NeuroClimax™ products are manufactured by CNS Curative Technologies LLC.

According to the company's existing product information, the formulations are manufactured in ISO 5-certified sterile cleanroom facilities.

Information about the specific manufacturing environment, batch documentation, quality controls, and product testing should be confirmed against the company's supporting records.

Customers seeking additional manufacturing or product-quality information can contact CNS Curative Technologies directly.

Scientific Research and References

The following scientific references are retained from CNS Curative's original product documentation.

• Costa, A., et al. Frontiers in Behavioral Neuroscience. 2015;9:253.
• Dagda, R.K., & Das Banerjee, T. Reviews in the Neurosciences. 2015;26(3):359–370.
• Hertz, N.T., et al. Cell. 2013;154(4):737–747.
• Soman, S.K., et al. Journal of Neuroscience Research. 2021;99(9):2134–2155.
• Ostrovskaya, R.U., et al. Bulletin of Experimental Biology and Medicine. 2008;146(3):334–337.
• Marcer, D., & Hopkins, S.M. Age and Ageing. 1977;6(2):123–131.

These publications concern biological pathways, experimental investigations, and individual compounds. They do not, by themselves, demonstrate the clinical safety or effectiveness of the finished NeuroClimax Gold (Max) product.

For further information about the company's scientific background and research activities, visit CNS Curative Technologies.

Intellectual Property and Product Development

CNS Curative Technologies identifies the following provisional patent application in its existing product documentation:

• U.S. Provisional Patent Application Number: 63/897,520.
• Application Title: Treatment of Cognitive Decline and Fatigue With Intranasal Nootropic Formulations.
• First Named Inventor: Raul Y. Dagda.
• Applicant/Assignee: CNS Curative Technologies LLC.
• Reference: FHW081752.

This information describes the company's reported intellectual-property filing. A provisional application does not itself establish that a patent has been granted or that the product has received regulatory approval.

NeuroClimax™ is identified by CNS Curative Technologies LLC as its trademark.

Before Ordering NeuroClimax Gold™ (Max)

Review the product's complete ingredient information, current labeling, directions, warnings, and ordering terms before making a purchasing decision.

If you have questions about the formulation, ingredient concentrations, product suitability, or supporting documentation, contact CNS Curative Technologies.

Seek advice from an appropriately qualified healthcare professional regarding individual medical considerations.

Current pricing, availability, and purchasing options are displayed separately on this product page.

Helpful information:

• Contact CNS Curative Technologies
• Shipping Information
• Returns and Refund Information

About CNS Curative Technologies

CNS Curative Technologies LLC
300 East 2nd Street
15th Floor, Suite 1512
Reno, Nevada 89501
USA

Phone: 775-376-0613
Email: contact@cnscurative.com

Company Website: www.cnscurative.com

Important Scientific and Safety Information

Scientific information concerning NeuroClimax Gold (Max) and its ingredients is based on the company's identified scientific literature, including mechanistic, experimental, and preclinical research unless otherwise indicated.

Biological findings involving individual ingredients or experimental models do not necessarily establish the clinical safety, effectiveness, appropriate dosing, or therapeutic benefits of the finished NeuroClimax Gold (Max) formulation.

Product-specific regulatory status, safety documentation, labeling, and marketing claims should be confirmed with CNS Curative Technologies and appropriately qualified regulatory professionals.